IPF treatment SM001-055 was generally safe and improved lung function, according to top-line data from a Phase 2a trial.

As his birthday approaches, columnist Sam Kirton shares what has transpired in his life since he began this latest trip ...

Many factors helped columnist Sam Kirton know when it was time to stop working so he could better attend to his health issues with IPF.

IPF's effects are relentless, says columnist Charlene Marshall, who faced various knee surgery complications because of her lung disease.

Nerandomilast demonstrated it was able to outperform a placebo at improving lung function in IPF or preventing its decline ...

Pulmonary Fibrosis Awareness Month may be coming to a close, but it's important to keep the momentum going, columnist Sam Kirton says.

A University of Colorado professor has won the 2024 Alton Ochsner Award Relating Smoking and Disease for his work into how genetic and environmental factors, including smoking, contribute to a ...

Avalyn Pharma has started a Phase 2b clinical trial testing the safety and efficacy of AP01, its investigational inhaled formulation of pirfenidone, in adults with progressive pulmonary fibrosis (PF).

Living with pulmonary fibrosis is already a daunting challenge, but when coupled with a sleep disorder like sleep apnea, the burden becomes even heavier. Sleep apnea, a condition in which breathing ...